Navigation Links
GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
Date:3/8/2010

ST. JOSEPH, Mich., March 8 /PRNewswire/ -- GeneGo announces the release of the first set of tools and content to come out of its industry-FDA MetaTox™ partnership program. The MetaTox partnership is developing a unique comprehensive systems toxicology suite designed for compound safety assessment in chemical and pharmaceutical R&D.

ToxHunter will be made available as an add-on to existing licenses of GeneGo's MetaCore™ and/or MetaDrug™ systems biology and systems pharmacology platforms.

ToxHunter includes a unique, detailed ontology of compound-induced pathological observations covering 7 target organs in the initial release, as well as a comprehensive, manually-curated knowledgebase of gene, protein, metabolite, and chemical associations to pathology terms that is searchable by pathology, toxicant, or gene, protein & metabolite biomarkers. ToxHunter also enables new experimental analysis and visualization tools such as an exclusive enrichment module for identifying specific gene-pathology associations, and a suite of new toxicity-focused pathway maps and QSAR models.

"It is immensely exciting to see the ideas and input of the MetaTox partnership come to fruition through the hard-work and dedication of the GeneGo team," said Richard Brennan, Director of Toxicology at GeneGo. "This initial release provides the community with a unique and powerful set of tools to help make sense of the flood of molecular data being generated by modern safety assessment groups. The next 12-18 months will see a further expansion of the capability of the platform as more of the tools developed by the partnership are released."

"It is very important to GeneGo and our end users that we build these tools and content in collaboration with partners as they know exactly what they need and what is currently missing in the marketplace," said Julie Bryant, VP Business Development. "We truly believe we have delivered important productivity tools to the tox field based on the extremely positive feedback we have already received from ToxHunter demonstrations."

GeneGo will be demonstrating ToxHunter at the annual meeting of the Society of Toxicology in Salt Lake City, Utah, this week (booth #1937, March 7-11), and is offering a 50% discount on the full price to anyone who licenses this new ToxHunter prior to release (offer good through June 30th, 2010 with a signed purchase agreement and payment).

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 6.1, assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 6.1 is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase represents the knowledge base for MetaCore.

For more information, please visit the company's web site at www.genego.com.

ToxHunter™, MetaCore™, MetaBase™ and MetaDrug™ are trademarks of GeneGo, Inc.

SOURCE GeneGo, Inc.

Back to top

RELATED LINKS
http://www.genego.com

'/>"/>

SOURCE GeneGo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GeneGo Receives SBIR Grant
2. GeneGo is Awarded NCI Grant for Development of Systems Biology Platform for Integrative Data Analysis in Cancer
3. Pi2 Solutions Releases the Latest Version of its Product Literature Database System for the Biopharmaceutical Industry
4. CEL-SCI Corporation Releases Letter to Shareholders
5. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
6. SpectraScience Releases Shareholder Newsletter
7. Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics
8. Lilly Releases Latest Value of Medicine Resource Guide About Key Issues Facing the Pharmaceutical Industry
9. ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists
10. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
11. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
Breaking Medicine News(10 mins):